v3.26.1
Consolidated Balance Sheets (Unaudited) - USD ($)
Mar. 31, 2026
Dec. 31, 2025
Current assets:    
Prepaid expense $ 61,975 $ 6,315
Marketable securities held in trust account - current 22,190  
Total current assets 84,165 6,315
Noncurrent assets:    
Marketable securities held in trust account 807,697 718,072
Total noncurrent assets 807,697 718,072
Total assets 891,862 724,387
Current liabilities:    
Accrued expenses and other liabilities 475,157 590,801
Redemption liability 22,190
Promissory notes and loan payable to Sponsor 1,880,216 1,431,299
Total current liabilities 2,377,563 2,022,100
Noncurrent liabilities:    
Deferred underwriting commissions 950,000 950,000
Total noncurrent liabilities 950,000 950,000
Total liabilities 3,327,563 2,972,100
Commitment and contingencies (Note 6)
Ordinary shares subject to possible redemption, 21,962 and 22,664 shares at redemption value of $36.78 and $31.68 per share at March 31, 2026 and December 31, 2025, respectively 807,697 718,072
Ordinary shares, par value $0.001, authorized 50,000,000 shares; 3,205,000 and 3,205,000 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively, excluding 21,962 and 22,664 shares subject to possible redemption 3,205 3,205
Additional paid-in capital 8,148,090 8,259,905
Accumulated deficit (11,394,693) (11,228,895)
Total stockholders’ deficit (3,243,398) (2,965,785)
Total liabilities and stockholders’ deficit $ 891,862 $ 724,387